Genefitletics

Genefitletics was founded in the year 2020 with an audacious mission “What if we could read about chronic diseases & cancer in the history books as an epidemic which used to exist in the past not in the current prescription medicines? Genefitletics, a deeptech company, has built a revolutionary system biology platform that utilises next generation sequencing, advanced statistical techniques & proprietary machine learning models to collect, process, analyse & interpret India & Singapore specific molecular data in order to 1.Predict-Onset of hard to detect metabolic diseases & establish their correlation with cancer 2.Build- Lab developed tests that detects metabolic diseases & cancer at an earliest stage & identifies molecular targets involved in their onset 3.Deliver-Precision Therapeutics such as nutrition or small molecule drugs that disable the targets to prevent disease onset or recurrence 4.Integrate-Clinical, molecular & longitudinal data to enable healthcare practitioners make real time data driven decisions to deliver personalised care & therapies & improvement efficacy of their treatments Current portfolio of lab developed tests, trained by proprietary 20 billion molecular datasets, include 1.ORAHYG Pro- Full body biochemistry test that measures & quantifies gut & oral microbiome functions & cellular health to predict onset of type 2 diabetes, CVD, CKD & IBD & deliver disease modifiable precision therapeutics interventions. The test also has inbuilt mathematical models that predicts insulin response to 317 foods, assesses your biological age & gives your amino acid & triglyceride profile at cellular level. 2.LILLBIO-This test measures gut microbiome & cellular functions to detect onset of autism at an earliest stage & deliver disease modifiable interventions. 3.ORAONCO-This test measures oral microbiome & cellular functions to detect oral cancer at an earliest stage & combine disease modifiable interventions with standard of care therapies